相似文献
1
Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases.
Front Aging Neurosci. 2020 Nov 26;12:232. doi: 10.3389/fnagi.2020.00232. eCollection 2020.
2
Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.
Int Rev Neurobiol. 2015;121:59-86. doi: 10.1016/bs.irn.2015.05.003. Epub 2015 Jun 19.
3
Clinical proteomics in neurodegenerative disorders.
Acta Neurol Scand. 2008 Jul;118(1):1-11. doi: 10.1111/j.1600-0404.2007.00985.x. Epub 2008 Feb 13.
4
The Big Bluff of Amyotrophic Lateral Sclerosis Diagnosis: The Role of Neurodegenerative Disease Mimics.
Neurodegener Dis. 2015;15(6):313-21. doi: 10.1159/000435917. Epub 2015 Jul 30.
5
Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Neurol Neurochir Pol. 2019;53(2):99-112. doi: 10.5603/PJNNS.a2019.0013. Epub 2019 Mar 11.
6
Biomarkers in Neurodegenerative Diseases.
Adv Neurobiol. 2017;15:491-528. doi: 10.1007/978-3-319-57193-5_20.
7
The Unbiased Search of Biomarkers in Neurodegenerative Diseases.
Curr Pharm Biotechnol. 2016;17(5):471-9. doi: 10.2174/138920101705160303165719.
8
Gene discovery and validation for neurodegenerative diseases.
Drug Discov Today. 2003 Jan 1;8(1):39-46. doi: 10.1016/s1359644602025400.
9
Dendritic Spine Pathology in Neurodegenerative Diseases.
Annu Rev Pathol. 2016 May 23;11:221-50. doi: 10.1146/annurev-pathol-012615-044216. Epub 2016 Feb 22.
10
Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Pharmacol Res. 2005 Jan;51(1):1-17. doi: 10.1016/j.phrs.2004.05.005.
引用本文的文献
1
Proteomic profiling identifies serpin G1, ApoA-II, and LBP as potential biomarkers of dementia in an Egyptian cohort.
Alzheimers Dement (Amst). 2025 Aug 24;17(3):e70172. doi: 10.1002/dad2.70172. eCollection 2025 Jul-Sep.
2
Neuro-Nutrition and Exercise Synergy: Exploring the Bioengineering of Cognitive Enhancement and Mental Health Optimization.
Bioengineering (Basel). 2025 Feb 19;12(2):208. doi: 10.3390/bioengineering12020208.
3
Comparative- and network-based proteomic analysis of bacterial chondronecrosis with osteomyelitis lesions in broiler's proximal tibiae identifies new molecular signatures of lameness.
Sci Rep. 2023 Apr 12;13(1):5947. doi: 10.1038/s41598-023-33060-y.
本文引用的文献
1
Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
Int J Mol Sci. 2018 Dec 20;20(1):4. doi: 10.3390/ijms20010004.
2
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
Nat Neurosci. 2019 Jan;22(1):65-77. doi: 10.1038/s41593-018-0294-y. Epub 2018 Dec 17.
3
Abnormal RNA stability in amyotrophic lateral sclerosis.
Nat Commun. 2018 Jul 20;9(1):2845. doi: 10.1038/s41467-018-05049-z.
4
Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects.
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):362-376. doi: 10.1080/21678421.2018.1433689. Epub 2018 Jan 31.
5
A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
EMBO Mol Med. 2018 Jan;10(1):48-62. doi: 10.15252/emmm.201708202.
6
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115.
7
Altered nucleocytoplasmic proteome and transcriptome distributions in an in vitro model of amyotrophic lateral sclerosis.
PLoS One. 2017 Apr 28;12(4):e0176462. doi: 10.1371/journal.pone.0176462. eCollection 2017.
8
Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.
J Neural Transm (Vienna). 2015 Oct;122(10):1475-97. doi: 10.1007/s00702-015-1404-6. Epub 2015 May 6.
9
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
Acta Neuropathol. 2015 Apr;129(4):469-91. doi: 10.1007/s00401-014-1380-1. Epub 2014 Dec 31.
10
Olfactory bulb involvement in neurodegenerative diseases.
Acta Neuropathol. 2014 Apr;127(4):459-75. doi: 10.1007/s00401-014-1261-7. Epub 2014 Feb 20.
Zotero 插件